Catalent Inc (NYSE:CTLT)
$ 55.466 -0.144 (-0.26%) Market Cap: 10.04 Bil Enterprise Value: 14.89 Bil PE Ratio: 0 PB Ratio: 2.78 GF Score: 81/100

Catalent Inc at Barclays Global Healthcare Conference Transcript

Mar 12, 2020 / 02:15PM GMT
Release Date Price: $44.01 (-4.43%)
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

Thank you, and good morning, and welcome to the final day of the Barclays Virtual Global Healthcare Conference. Pleased to be joined now with Catalent CFO, Wetteny Joseph; as well as Head of Investor Relations, Paul Surdez. Wetteny is going to walk us through a few slides, and then we're going to do some Q&A.

So with that, thanks again for joining us, Catalent. And Wetteny, I'll turn it over to you.

Wetteny N. Joseph
Catalent, Inc. - Senior VP & CFO

Thank you, Jack, for having Catalent at your virtual conference, and I'm happy to give everyone an overview and update on the business today. The slides I will be reviewing today can be found on Catalent's IR website under Presentations.

Before I get started, please let me comment on our forward-looking statements and non-GAAP financial measures. I will be making forward-looking statements today, and we encourage you to review our full list of risk factors relevant to evaluating these statements, which

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot